Innovate Biopharmaceuticals Doses First Patient in Phase 3 Clinical Trial CeD LA3001 Biotech Investing
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 Biotech Investing
Life Science Big News Roundup: Lexaria Completes Initial Project with Canada’s National Research Council; PreveCeutical Grants Asterion Option to Purchase a 51% Interest in Sol-Gel IP Life Science Investing
